Certolizumab pegol Active Not Recruiting Phase 4 Trials for Anterior Uveitis (AU) / Axial Spondyloarthritis (AxSpA) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03020992A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU